Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Diabetes and glaucoma share several common risk factors and pathophysiological similarities. Elevated intraocular pressure, a key pathogenic feature of glaucoma and its progression, has been found to be influenced in diabetic patients. Furthermore, a link between poor glycemic control and increased intraocular pressure has been documented. Given the rising prevalence of diabetes mellitus and its emergence as a new pandemic with widespread effects, it is crucial to thoroughly study its impact on various body systems and implement measures to reduce these adverse effects. Therefore, this study aims to investigate the variation in intraocular pressure and its relationship with different pathogenic risk factors in diabetes mellitus patients to develop effective prevention strategies.

Aim: To study the variation in intraocular pressure among the subjects with Type II Diabetes Mellitus Settings and Study Design: This analytical cross-sectional study conducted at KGMU, Ophthalmology OPD.

Methods And Materials: Study has been conducted on a total of 140 participants, comprising of 70 Type II DM cases and 70 age, gender-matched controls in 1year duration. Type II DM was confirmed by diagnosis while controls were selected to match in age & gender without diabetes. IOP measurement was done using non-contact tonometry and central corneal thickness was measured by non-contact method using NIDEK CEM-530 specular microscope. Regression analysis was used to assess association between Type II DM and IOP variation. Statistical analysis of the data was done using IBM SPSS Stats 25.0 version with Student t-test, Chi-square test, ANOVA, and Pearson's correlation with 95% CI is used. P <0.05 is considered significant.

Result: Significant distinction in IOP between the between cases and control group is observed. And, also more the duration of diabetes with poor glycemic control may lead to raised IOP.

Conclusion: The study rules out the risk factors for raised IOP in general & diabetic population. Thus, emphasizing the need for meticulous ocular care in diabetic individuals.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12088549PMC
http://dx.doi.org/10.4103/jfmpc.jfmpc_1270_24DOI Listing

Publication Analysis

Top Keywords

intraocular pressure
20
diabetes mellitus
12
risk factors
8
variation intraocular
8
study conducted
8
study
6
intraocular
5
pressure
5
diabetes
5
comparative study
4

Similar Publications

Optimization of ciliary body cyclophotocoagulation settings: a randomized and controlled pilot study.

Can J Ophthalmol

September 2025

Département d'Ophtalmologie et d'Ophtalmologie et d'Oto-Rhino-Laryngologie-Chirurgie Cervico-Faciale, Faculté de Médecine, Université Laval, QC, Canada; Centre Universitaire d'Ophtalmologie, Hôpital du Saint-Sacrement, Centre Hospitalier Universitaire de Québec-Université Laval, QC, Canada.

Objective: To compare the efficacy of different settings in continuous-wave transscleral cyclophotocoagulation (CW-TSCPC).

Design: Prospective, randomized, triple-blind clinical trial in a single tertiary center.

Participants: Adult glaucoma patients who need continuous wave-transscleral cyclophotocoagulation to control intraocular pressure (IOP) or prevent or treat ocular pain/discomfort secondary to increased IOP.

View Article and Find Full Text PDF

Objective: To describe observed intraocular pressure (IOP) changes following vitrectomy (PPV) surgery and PPV combined with phacoemulsification in eyes with and without glaucoma.

Methods: A total of 20,894 patients from the American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight) who underwent vitrectomy surgery for epiretinal membrane or vitreous opacities from January 2016 to March 2023 were included. Mean IOPs from postoperative day 1, days 2-10, days 11-30, and then monthly through 6 months were compared to baseline.

View Article and Find Full Text PDF

Purpose: To assess the clinical outcomes of Hydrus Microstent implantation with cataract extraction for the treatment of open angle glaucoma (OAG) over a maximum of 4 years.

Design: Retrospective, single-center, single-arm, longitudinal cohort study.

Subjects: 308 patients (464 eyes) with OAG who underwent Hydrus Microstent implantation with cataract extraction between February 2019 and December 2021, followed for a median (interquartile range, IQR) of 2.

View Article and Find Full Text PDF

Purpose: To evaluate the impact of prostaglandin-associated periorbitopathy (PAP) severity on the surgical outcomes of trabeculectomy (LEC) and Ahmed Glaucoma Valve (AGV) implantation in patients with primary open-angle glaucoma.

Methods: In this propensity score-matched retrospective cohort study, a total of 106 eyes with uncontrolled glaucoma were included. Postoperative follow-ups were conducted at 1, 3, 6, 9, and 12 months.

View Article and Find Full Text PDF

Ab-Externo MicroShunt versus Trabeculectomy in Primary Open-Angle Glaucoma:5-Year Safety Results from a Randomized, Multicenter Study.

Ophthalmol Glaucoma

September 2025

NIHR Moorfields Biomedical Research Centre, Moorfields Eye Hospital and UCL Institute of Ophthalmology, London, England; Discipline of Clinical Ophthalmology and Eye Health, University of Sydney, Sydney, New South Wales, Australia.

Purpose: To compare the long-term safety of MicroShunt implantation with trabeculectomy in eyes with primary open-angle glaucoma (POAG).

Methods: This was a 3-year observational extension of a 2-year prospective randomized trial comparing clinical outcomes of MicroShunt implantation with trabeculectomy, both augmented with mitomycin C. Adverse events (AEs), intraocular pressure (IOP), and IOP-lowering medication use were recorded 36, 48, and 60 months after initial randomization.

View Article and Find Full Text PDF